Perspective Therapeutics (CATX) Gross Margin (2010 - 2023)
Perspective Therapeutics recorded quarterly Gross Margin of 0.8% in Q4 2023, down 97.64% quarter-over-quarter from 33.78% in Q3 2023.
Perspective Therapeutics' Gross Margin history runs 14 years deep, the most recent figure standing at 0.8% for Q4 2023.
- In Q4 2023, Gross Margin changed N/A year-over-year to 0.8%; the TTM figure through Dec 2023 stood at 233.93% (changed N/A YoY), while the FY2023 annual figure was 100.0%, changed N/A from the prior year.
- Gross Margin came in at 0.8% for Q4 2023 at Perspective Therapeutics, down from 33.78% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 59.24% in Q1 2020 to a low of 0.8% in Q4 2023.
- A 5-year average of 40.89% and a median of 45.69% in 2019 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin soared 1984 bps in 2019 and plunged 2291 bps in 2023, its largest moves.
- Perspective Therapeutics' Gross Margin stood at 50.36% in 2019, then dropped by 2 bps to 49.47% in 2020, then decreased by 12 bps to 43.32% in 2021, then plunged by 44 bps to 24.11% in 2022, then sank by 97 bps to 0.8% in 2023.
- According to Business Quant data, Gross Margin over the past three periods registered 0.8%, 33.78%, and 16.53% for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 0.80% |
| Sep 30, 2023 | 33.78% |
| Jun 30, 2023 | 16.53% |
| Mar 31, 2023 | 26.61% |
| Sep 30, 2022 | 24.11% |
| Jun 30, 2022 | 36.97% |
| Mar 31, 2022 | 49.52% |
| Dec 31, 2021 | 43.32% |
| Sep 30, 2021 | 40.13% |
| Jun 30, 2021 | 49.67% |
| Mar 31, 2021 | 52.38% |
| Dec 31, 2020 | 49.47% |
| Sep 30, 2020 | 52.27% |
| Jun 30, 2020 | 46.99% |
| Mar 31, 2020 | 59.24% |
| Dec 31, 2019 | 50.36% |
| Sep 30, 2019 | 53.39% |
| Jun 30, 2019 | 45.69% |
| Mar 31, 2019 | 45.69% |
| Dec 31, 2018 | 40.18% |
| Sep 30, 2018 | 33.55% |
| Jun 30, 2018 | 27.64% |
| Mar 31, 2018 | 38.72% |
| Dec 31, 2017 | 34.57% |
| Sep 30, 2017 | 21.88% |
| Jun 30, 2017 | 36.35% |
| Mar 31, 2017 | 22.85% |
| Dec 31, 2016 | -0.10% |
| Sep 30, 2016 | 4.44% |
| Jun 30, 2016 | -4.29% |
| Mar 31, 2016 | 5.51% |
| Dec 31, 2015 | 2.52% |
| Sep 30, 2015 | 6.58% |
| Jun 30, 2015 | 15.29% |
| Mar 31, 2015 | 4.77% |
| Dec 31, 2014 | -3.56% |
| Sep 30, 2014 | -5.26% |
| Jun 30, 2014 | -14.34% |
| Mar 31, 2014 | 4.49% |
| Dec 31, 2013 | -3.12% |
| Sep 30, 2013 | -7.36% |
| Jun 30, 2013 | 11.54% |
| Mar 31, 2013 | 14.85% |
| Dec 31, 2012 | -16.26% |
| Sep 30, 2012 | -1.93% |
| Jun 30, 2012 | 17.82% |
| Mar 31, 2012 | 15.50% |
| Dec 31, 2011 | 16.19% |
| Sep 30, 2011 | 5.47% |
| Jun 30, 2011 | 36.34% |
| Mar 31, 2011 | 25.34% |
| Dec 31, 2010 | 10.28% |
| Sep 30, 2010 | 16.25% |